172 related articles for article (PubMed ID: 36682657)
1. Zn
Wu F; Cheng Y; Zhou J; Liu X; Lin R; Xiang S; Liu Z; Wang C
Int J Biol Macromol; 2023 Apr; 234():123320. PubMed ID: 36682657
[TBL] [Abstract][Full Text] [Related]
2. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats.
Sasikumar P; Gomathi S; Anbazhagan K; Abhishek A; Paul E; Vasudevan V; Sasikumar S; Selvam GS
J Biomed Sci; 2014 Aug; 21(1):86. PubMed ID: 25175550
[TBL] [Abstract][Full Text] [Related]
4. Genetically engineered Lactobacillus plantarum WCFS1 constitutively secreting heterologous oxalate decarboxylase and degrading oxalate under in vitro.
Sasikumar P; Gomathi S; Anbazhagan K; Baby AE; Sangeetha J; Selvam GS
Curr Microbiol; 2014 Nov; 69(5):708-15. PubMed ID: 24989485
[TBL] [Abstract][Full Text] [Related]
5. Effect of Copper and Zinc Ions on Biochemical and Molecular Characteristics of Calcium Oxalate Renal Stones: a Controlled Clinical Study.
Taha SAY; Shokeir AA; Mortada WI; Awadalla A; Barakat LAA
Biol Trace Elem Res; 2024 Feb; 202(2):410-422. PubMed ID: 37191760
[TBL] [Abstract][Full Text] [Related]
6. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
[TBL] [Abstract][Full Text] [Related]
7. Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease.
Albert A; Tiwari V; Paul E; Ganesan D; Ayyavu M; Kujur R; Ponnusamy S; Shanmugam K; Saso L; Govindan Sadasivam S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):426-433. PubMed ID: 28118755
[TBL] [Abstract][Full Text] [Related]
8. Increased abundance of bacteria of the family Muribaculaceae achieved by fecal microbiome transplantation correlates with the inhibition of kidney calcium oxalate stone deposition in experimental rats.
Wang Y; Sun J; Xie S; Zhou Y; Wang T; Liu Z; Li C; Gao L; Pan T
Front Cell Infect Microbiol; 2023; 13():1145196. PubMed ID: 37313343
[TBL] [Abstract][Full Text] [Related]
9. Role of gut microbiota against calcium oxalate.
Sadaf H; Raza SI; Hassan SW
Microb Pathog; 2017 Aug; 109():287-291. PubMed ID: 28624518
[TBL] [Abstract][Full Text] [Related]
10. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
Peck AB; Canales BK; Nguyen CQ
Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
[TBL] [Abstract][Full Text] [Related]
11. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
[TBL] [Abstract][Full Text] [Related]
12. Short-Chain Fatty Acids Reduced Renal Calcium Oxalate Stones by Regulating the Expression of Intestinal Oxalate Transporter SLC26A6.
Liu Y; Jin X; Ma Y; Jian Z; Wei Z; Xiang L; Sun Q; Qi S; Wang K; Li H
mSystems; 2021 Dec; 6(6):e0104521. PubMed ID: 34783577
[TBL] [Abstract][Full Text] [Related]
13. Adsorption of ethylenediaminetetraacetic dianhydride modified oxalate decarboxylase on calcium oxalate.
Cai XH; Lin RH; Wu J; He JB; Wu YC; Wang XY
Biotech Histochem; 2018; 93(3):220-229. PubMed ID: 29393700
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota affect the formation of calcium oxalate renal calculi caused by high daily tea consumption.
Chen F; Bao X; Liu S; Ye K; Xiang S; Yu L; Xu Q; Zhang Y; Wang X; Zhu X; Ying J; Shen Y; Ji W; Si S
Appl Microbiol Biotechnol; 2021 Jan; 105(2):789-802. PubMed ID: 33404827
[TBL] [Abstract][Full Text] [Related]
15. Impact of intestinal flora on calcium oxalate stones.
Wang C; Dong X; Yin X; Zhou F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Nov; 46(11):1285-1289. PubMed ID: 34911864
[TBL] [Abstract][Full Text] [Related]
16. Beneficial roles of gastrointestinal and urinary microbiomes in kidney stone prevention via their oxalate-degrading ability and beyond.
Noonin C; Thongboonkerd V
Microbiol Res; 2024 May; 282():127663. PubMed ID: 38422861
[TBL] [Abstract][Full Text] [Related]
17. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
18. Vinegar reduced renal calcium oxalate stones by regulating acetate metabolism in gut microbiota and crystal adhesion in rats.
Liu Y; Jin X; Ma Y; Sun Q; Li H; Wang K
Int Urol Nephrol; 2022 Oct; 54(10):2485-2495. PubMed ID: 35852714
[TBL] [Abstract][Full Text] [Related]
19. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
[TBL] [Abstract][Full Text] [Related]
20. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
